The World Health Organization (WHO) has added aid in the treatment of Covid19 calling it “lifesaving”-interleukin-6 receptor blockers– only the second drugs to be recommended as effective against the disease – because the pandemic continues to accelerate across the globe.
The WHO said after observing the medicines worked particularly well when used along with corticosteroids, which were recommended in September 2020. These drugs offer hope for patients and families who are suffering from the devastating impact of severe and important COVID-19.
Patients with severe cases of COVID-19 often suffer from an overreaction of the system and therefore the interleukin-6 blocking drugs – tocilizumab and sarilumab – act to suppress the overreaction.
Data source: World Health Organization and news agencies